Dual signals may drive early breast cancer

Researchers from the lab of Joan Brugge, Harvard Medical School professor of cell biology, may have uncovered one of the central mechanisms of breast cancer. They found that dual signals provided by ErbB2, a cancer-associated gene commonly known as HER2, appear to be required to disrupt the framework of a breast gland during early tumor development.